about
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...
Read More
0.80
-0.02
(-2.44%)
158.9K
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
InflaRx N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..